{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T01:58:10Z","timestamp":1791165490886,"version":"4.1.0"},"reference-count":36,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2020,9,14]],"date-time":"2020-09-14T00:00:00Z","timestamp":1600041600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2017R1D1A1B03033382"],"award-info":[{"award-number":["NRF-2017R1D1A1B03033382"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2020R1I1A1A01060447"],"award-info":[{"award-number":["NRF-2020R1I1A1A01060447"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,9,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Cardiovascular risk increases following herpes zoster. We investigated whether treatment with antiviral agents, steroids, and common cardiovascular medications was associated with the risk of postherpetic cardiovascular events.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This was a nationwide population-based, retrospective, cohort study using the National Health Insurance Service health claims data in Korea. We included patients with a first-ever diagnosis of herpes zoster in 2003\u20132014 and no prior cardiovascular event. The primary outcome was the occurrence of composites of myocardial infarction (International Statistical Classification of Diseases, Tenth Revision, code I21) and stroke (codes I60\u2013I63) since the herpes zoster. We analyzed the exposure (intravenous or oral administration) to antiviral agents, steroids, antithrombotics, and statins within \u00b17 days from the index date of herpes zoster diagnosis. Follow-up was performed until occurrence of the primary outcome, death, or 31 December 2015, whichever came first.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of 84 993 patients with herpes zoster, the proportions of patients who received the treatment with antiviral agents, steroids, antithrombotics, and statins were 90.5%, 48.0%, 9.1%, and 7.9%, respectively. During the mean (standard deviation) follow-up period of 5.4 (3.1) years, 1523 patients experienced the primary outcome. Multivariate Cox regression analysis demonstrated that treatment with antiviral agents (adjusted hazard ratio, 0.82; 95% confidence interval, .71\u2013.95) and statins (0.71; .59\u2013.85) were significantly associated with the lower risk of primary outcome. Use of antithrombotics and steroids were not associated with the risk.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>After herpes zoster, treatment with antiviral agents was significantly associated with lower risk of cardiovascular events. We need more information on the cardiovascular protective role of herpes zoster treatments.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/cid\/ciaa1384","type":"journal-article","created":{"date-parts":[[2020,9,11]],"date-time":"2020-09-11T07:12:31Z","timestamp":1599808351000},"page":"758-764","source":"Crossref","is-referenced-by-count":22,"title":["Association Between the Risk for Cardiovascular Events and Antiviral Treatment for Herpes Zoster"],"prefix":"10.1093","volume":"73","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0156-9736","authenticated-orcid":false,"given":"Jinkwon","family":"Kim","sequence":"first","affiliation":[{"name":"Department of Neurology, Yongin Severance Hospital, Yonsei University College of Medicine, Yongin, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jimin","family":"Jeon","sequence":"additional","affiliation":[{"name":"Department of Neurology, Yongin Severance Hospital, Yonsei University College of Medicine, Yongin, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6328-6948","authenticated-orcid":false,"given":"Hye Sun","family":"Lee","sequence":"additional","affiliation":[{"name":"Biostatistics Collaboration Unit, Yonsei University College of Medicine, Seoul, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5585-7739","authenticated-orcid":false,"given":"Kyung-Yul","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Neurology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,9,14]]},"reference":[{"key":"2021090720242711300_CIT0001","doi-asserted-by":"crossref","first-page":"724","DOI":"10.2146\/ajhp090118","article-title":"Herpes zoster and vaccination: a clinical review","volume":"67","author":"Adams","year":"2010","journal-title":"Am J Health Syst Pharm"},{"key":"2021090720242711300_CIT0002","doi-asserted-by":"crossref","first-page":"547","DOI":"10.3390\/jcm8040547","article-title":"Does herpes zoster increase the risk of stroke and myocardial infarction? a comprehensive review","volume":"8","author":"Wu","year":"2019","journal-title":"J Clin Med"},{"key":"2021090720242711300_CIT0003","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/infdis\/jiy425","article-title":"Varicella zoster virus vasculopathy","volume":"218","author":"Nagel","year":"2018","journal-title":"J Infect Dis"},{"key":"2021090720242711300_CIT0004","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.jacc.2017.05.015","article-title":"Herpes zoster increases the risk of stroke and myocardial infarction","volume":"70","author":"Kim","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"2021090720242711300_CIT0005","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.4065\/mcp.2011.0309","article-title":"Antiviral drugs for viruses other than human immunodeficiency virus","volume":"86","author":"Razonable","year":"2011","journal-title":"Mayo Clin Proc"},{"key":"2021090720242711300_CIT0006","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1093\/cid\/ciu296","article-title":"Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America","volume":"59","author":"Stevens","year":"2014","journal-title":"Clin Infect Dis"},{"key":"2021090720242711300_CIT0007","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1212\/WNL.0b013e3181d31e5c","article-title":"Herpes zoster ophthalmicus and the risk of stroke: a population-based follow-up study","volume":"74","author":"Lin","year":"2010","journal-title":"Neurology"},{"key":"2021090720242711300_CIT0008","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1093\/cid\/ciu098","article-title":"Risk of stroke following herpes zoster: a self-controlled case-series study","volume":"58","author":"Langan","year":"2014","journal-title":"Clin Infect Dis"},{"key":"2021090720242711300_CIT0009","doi-asserted-by":"crossref","first-page":"e708","DOI":"10.1212\/WNL.0000000000010028","article-title":"Effect of herpes zoster vaccine and antiviral treatment on risk of ischemic stroke","volume":"95","author":"Yang","year":"2020","journal-title":"Neurology"},{"key":"2021090720242711300_CIT0010","first-page":"e15","article-title":"Cohort profile: the National Health Insurance Service-National Sample Cohort (NHIS-NSC), South Korea","volume":"46","author":"Lee","year":"2017","journal-title":"Int J Epidemiol"},{"key":"2021090720242711300_CIT0011","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.cmi.2016.03.003","article-title":"Risk of stroke and transient ischaemic attack after herpes zoster","volume":"22","author":"Kwon","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"2021090720242711300_CIT0012","doi-asserted-by":"crossref","first-page":"9692","DOI":"10.1038\/s41598-018-27941-w","article-title":"Beneficial effect of statins in patients receiving chronic hemodialysis following percutaneous coronary intervention: a nationwide retrospective cohort study","volume":"8","author":"Kim","year":"2018","journal-title":"Sci Rep"},{"key":"2021090720242711300_CIT0013","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s12933-019-0874-5","article-title":"Effect of pioglitazone in acute ischemic stroke patients with diabetes mellitus: a nested case-control study","volume":"18","author":"Woo","year":"2019","journal-title":"Cardiovasc Diabetol"},{"key":"2021090720242711300_CIT0014","doi-asserted-by":"crossref","first-page":"182","DOI":"10.3171\/2019.3.JNS183500","article-title":"The impact of statin therapy after surgical or endovascular treatment of cerebral aneurysms","volume":"133","author":"Song","year":"2020","journal-title":"J Neurosurg"},{"key":"2021090720242711300_CIT0015","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1161\/HYPERTENSIONAHA.118.11139","article-title":"Effect of adherence to antihypertensive medication on the long-term outcome after hemorrhagic stroke in Korea","volume":"72","author":"Kim","year":"2018","journal-title":"Hypertension"},{"key":"2021090720242711300_CIT0016","first-page":"76","article-title":"The accuracy of ICD codes for cerebrovascular diseases in medical insurance claims","volume":"33","author":"Park","year":"2000","journal-title":"Korean J Prev Med"},{"key":"2021090720242711300_CIT0017","doi-asserted-by":"crossref","first-page":"e005025","DOI":"10.1136\/bmjopen-2014-005025","article-title":"A coronary heart disease prediction model: the Korean Heart Study","volume":"4","author":"Jee","year":"2014","journal-title":"BMJ Open"},{"key":"2021090720242711300_CIT0018","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.3904\/kjim.2018.170","article-title":"Current treatment status and medical costs for hemodialysis vascular access based on analysis of the Korean Health Insurance Database","volume":"33","author":"Lee","year":"2018","journal-title":"Korean J Intern Med"},{"key":"2021090720242711300_CIT0019","doi-asserted-by":"crossref","first-page":"382","DOI":"10.23876\/j.krcp.18.0128","article-title":"Impact of chronic kidney disease on mortality: a nationwide cohort study","volume":"38","author":"Kim","year":"2019","journal-title":"Kidney Res Clin Pract"},{"key":"2021090720242711300_CIT0020","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3389\/fneur.2019.00052","article-title":"The long-term effect of cancer on incident stroke: a Nationwide Population-Based Cohort Study in Korea","volume":"10","author":"Jang","year":"2019","journal-title":"Front Neurol"},{"key":"2021090720242711300_CIT0021","doi-asserted-by":"crossref","first-page":"e808","DOI":"10.3399\/bjgp12X659277","article-title":"Prescription of antiviral therapy after herpes zoster in general practice: who receives therapy?","volume":"62","author":"Forbes","year":"2012","journal-title":"Br J Gen Pract"},{"key":"2021090720242711300_CIT0022","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S1474-4422(09)70134-6","article-title":"Varicella zoster virus vasculopathies: diverse clinical manifestations, laboratory features, pathogenesis, and treatment","volume":"8","author":"Gilden","year":"2009","journal-title":"Lancet Neurol"},{"key":"2021090720242711300_CIT0023","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s13365-013-0183-9","article-title":"Varicella zoster virus vasculopathy: clinical features and pathogenesis","volume":"20","author":"Nagel","year":"2014","journal-title":"J Neurovirol"},{"key":"2021090720242711300_CIT0024","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1001\/archneurol.2009.271","article-title":"Infectious burden and risk of stroke: the northern Manhattan study","volume":"67","author":"Elkind","year":"2010","journal-title":"Arch Neurol"},{"key":"2021090720242711300_CIT0025","doi-asserted-by":"crossref","first-page":"e382","DOI":"10.1212\/NXI.0000000000000382","article-title":"Varicella zoster virus-infected cerebrovascular cells produce a proinflammatory environment","volume":"4","author":"Jones","year":"2017","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"2021090720242711300_CIT0026","doi-asserted-by":"crossref","first-page":"10527","DOI":"10.1128\/JVI.01546-16","article-title":"Varicella-zoster virus downregulates programmed death Ligand 1 and major histocompatibility complex class I in human brain vascular adventitial fibroblasts, perineurial cells, and lung fibroblasts","volume":"90","author":"Jones","year":"2016","journal-title":"J Virol"},{"key":"2021090720242711300_CIT0027","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1093\/clinids\/22.2.341","article-title":"Oral acyclovir therapy accelerates pain resolution in patients with herpes zoster: a meta-analysis of placebo-controlled trials","volume":"22","author":"Wood","year":"1996","journal-title":"Clin Infect Dis"},{"key":"2021090720242711300_CIT0028","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1212\/01.WNL.0000140708.62856.72","article-title":"Practice parameter: treatment of postherpetic neuralgia: an evidence-based report of the Quality Standards Subcommittee of the American Academy of Neurology","volume":"63","author":"Dubinsky","year":"2004","journal-title":"Neurology"},{"key":"2021090720242711300_CIT0029","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/jdv.13957","article-title":"European consensus-based (S2k) Guideline on the Management of Herpes Zoster\u2014guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV). Part 2. Treatment","volume":"31","author":"Werner","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2021090720242711300_CIT0030","doi-asserted-by":"crossref","first-page":"e1001919","DOI":"10.1371\/journal.pmed.1001919","article-title":"Acute cardiovascular events after herpes zoster: a self-controlled case series analysis in vaccinated and unvaccinated older residents of the United States","volume":"12","author":"Minassian","year":"2015","journal-title":"PLoS Med"},{"key":"2021090720242711300_CIT0031","doi-asserted-by":"crossref","first-page":"e0171182","DOI":"10.1371\/journal.pone.0171182","article-title":"Herpes zoster and the risk of ischemic and hemorrhagic stroke: a systematic review and meta-analysis","volume":"12","author":"Lian","year":"2017","journal-title":"PLoS One"},{"key":"2021090720242711300_CIT0032","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/j.vaccine.2019.01.023","article-title":"Effect of atorvastatin on humoral immune response to 23-valent pneumococcal polysaccharide vaccination in healthy volunteers: the StatVax randomized clinical trial","volume":"37","author":"Wildes","year":"2019","journal-title":"Vaccine"},{"key":"2021090720242711300_CIT0033","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.jacl.2010.08.007","article-title":"Myeloperoxidase, inflammation, and dysfunctional high-density lipoprotein","volume":"4","author":"Smith","year":"2010","journal-title":"J Clin Lipidol"},{"key":"2021090720242711300_CIT0034","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.antiviral.2013.06.018","article-title":"Treating influenza with statins and other immunomodulatory agents","volume":"99","author":"Fedson","year":"2013","journal-title":"Antiviral Res"},{"key":"2021090720242711300_CIT0035","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.it.2006.12.003","article-title":"Statins and the vascular endothelial inflammatory response","volume":"28","author":"Greenwood","year":"2007","journal-title":"Trends Immunol"},{"key":"2021090720242711300_CIT0036","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1056\/NEJMoa1603800","article-title":"Efficacy of the herpes zoster subunit vaccine in adults 70 years of age or older","volume":"375","author":"Cunningham","year":"2016","journal-title":"N Engl J Med"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/advance-article-pdf\/doi\/10.1093\/cid\/ciaa1384\/36500468\/ciaa1384.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/73\/5\/758\/40325886\/ciaa1384.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/73\/5\/758\/40325886\/ciaa1384.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,7]],"date-time":"2021-09-07T16:25:45Z","timestamp":1631031945000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/73\/5\/758\/5905502"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,14]]},"references-count":36,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2020,9,14]]},"published-print":{"date-parts":[[2021,9,7]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciaa1384","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,9,1]]},"published":{"date-parts":[[2020,9,14]]}}}